Navigation Links
Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
Date:9/20/2007

MEDIA, Pa., Sept. 20 /PRNewswire-FirstCall/ -- Synova Healthcare Group, Inc. (OTC Bulletin Board: SNVH), today announced that it completed the sale of approximately $3.3 million in aggregate notional principal amount of its 6.5% senior convertible promissory notes, Series B, due September 19, 2012, and related common stock purchase warrants. This sale was effected as the initial part of an ongoing private placement of notes and warrants in the aggregate notional principal amount of up to $5 million. The notes were sold to certain accredited investors and foreign investors.

The notes mature on September 19, 2012 and are convertible into shares of Synova common stock at a conversion rate of one share for every $1.00 of principal and accrued and unpaid interest converted, subject to anti-dilution adjustments for certain corporate transactions. Synova's obligations under the notes are unsecured.

As part of this offering, Synova issued a warrant to each purchaser of the notes. The warrants have a term of five years and are exercisable for shares of Synova common stock at a price of $1.00 per share, subject to anti-dilution adjustments for certain corporate transactions. Each warrant entitles the holder to acquire a number of shares of Synova common stock equal to 180% of the number of shares that such holder could acquire upon conversion of such holder's notes. Synova will use the net proceeds received from this offering to provide continued investment in the Today(R) Sponge, to further expand its growing portfolio of women's health care products, and for general corporate purposes.

The offer and sale of these notes required the consent of the holders of Synova's existing 6.5% senior convertible promissory notes due January 12, 2012. As consideration for these consents and certain other waivers of, and amendments to, various agreements related to the January notes, Synova and its subsidiaries agreed to grant to the holders of the January notes a
'/>"/>

SOURCE Synova Healthcare Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Synova Acquires Rights to Today Sponge Contraceptive, Plans Advertising Campaign
2. iGATE Completes Phase I Testing Of Meningitis Vaccine
3. Delhi Hospital Completes 100 Liver Transplants
4. Roche Completes Acquisition of BioVeris
5. Drug May Make Breathing Easier for Millions
6. Hundred million dollar gift for malaria institute
7. George Bush pledges 200 million dollars for AIDS relief
8. Hope for 11 million children facing death from illnesses
9. The forgotten epidemic killing millions
10. WHO and UNAIDS unveil plan to get 3 million AIDS patients on treatment by 2005
11. Over Six Million HIV Infected People In South Africa- Finds A Survey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...published in the Journal of Vertebral Subluxation ...ay offer significant benefits //to children suffer...research was conducted by Swiss chiropractor Yanni...ropractic Pediatric Association, who specializes i...
...h finding indicates that patients who were affecte...pse of multiple sclerosis (MS). Multiple Sclerosis...sheath that covers the nerve fibres. // Jorge Corr...ea Institute for Neurological Research in Buenos A...
...ered the fray of painkillers, especially the likes...relieve muscle soreness after a heavy work out or ...ine //equivalent of two cups of coffee, consumed b... by 50%. In the words of researcher Patrick O'Con...
... strain brought havoc to human community by killin...strain of virus was highly lethal and the affected...rein the defense mechanism of the body itself prov...cted. American researchers reconstructed this vir...
Other Medicine News:Health News:Chiropractic Care Helps Children With Learning Disorders and Dyslexia 2Health News:Chiropractic Care Helps Children With Learning Disorders and Dyslexia 3Health News:Work-outs, Not So Much of a ‘pain’ With Caffei 2
(Date:8/18/2008)...ewswire-USNewswire/ -- Boston University and Aubre...r for Human Genetics, Inc.,("CHG") and Director of...y,announced that CHG will no longer offer testing...agnostics, Inc., These patented tests include tes...1555G or Connexin 26 mutations, developmental diso...
(Date:8/18/2008)...al Trials Phase of Test Development Program, ORAN...-- Beckman,Coulter, Inc. (NYSE: BEC ) announced t...S. royalty obligation to Nephromics LLC, a Chestnu...lth. The license is for tests,related to the detec...ia, a,leading cause of maternal death. In addition...
(Date:8/18/2008)...18 /- Micromet, Inc.,(Nasda... novel, proprietary,antibodies for the treatment o...ll host a webcast and conference call this morning...ime (4:00 p.m. Central European,Time) to discuss t...urnal,SCIENCE on August 15, 2008., To access the ...
(Date:8/14/2008)...- AstraZeneca (NYSE: AZN )...h the National Cancer,Centre Singapore (NCCS) and ...anti-cancer compounds. The collaboration, which is...that was signed today, aims to further,build Astra... ultimately,speed up access to new medicines of po...
Breaking Medicine Technology:Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 2Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 1Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 2Experimental technique at GUMC offers real time analysis of breast cancer biopsies 6246 3National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High Tech World 6242 1National Network to End Domestic Violence Fund Introduces New Tool to Outsmart Abusers and Stalkers in Todays High Tech World 6242 2Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 1Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 2Survey Reveals Heartburn Sufferers Experience More Heartburn During the Holidays 6237 3First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 1First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 2First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 3First Ever Collaborative Summit on Breast Cancer Research Targets New Partnerships and Collaborative Solutions 6232 4
...zation with a Bavituximab Equivalent and Irradiate...From 0% in Controls in a,Preclinical Model of Brai...18, 2007,/PRNewswire-FirstCall/ -- Peregrine Pharm...cal company developing targeted,monoclonal antibod...rus (HCV) infection, today announced preclinical s...
..., Wash., April 18, 2007 /PRNewswire-FirstCall/ -- ...Falla, Ph.D, Chief,Scientific Officer, will presen...ll molecule peptide (lipohexapeptide) technology,a... will take place,at the Boston Convention & Ex... 9th. Dr. Falla,s presentation is scheduled for,We...
Other Medicine Technology:Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 2Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 3Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 4Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 5Data Presented at AACR Meeting Show Peregrine's Bavituximab,Equivalent Can Generate Curative Immune Responses as Part of a,Vaccine-Like Regimen in Preclinical Models of Aggressive Brain,Cancer 6Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 2Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 3Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 4
Latex agglutination inhibition slide test for the qualitative detection of hCG in urine.
Indirect hemagglutination test for the qualitative and quantitative determination of antibodies to Toxoplasma gondii in serum.
Hemagglutination slide test for the qualitative detection and quantitative determination of antibodies to streptococcal extracellular antigens in serum, plasma, or whole blood.
Color-enhanced slide agglutination test for the rapid qualitative and semi-quantitative detection of antistreptolysin O.
Medicine Products: